MEDICAL NEED PROGRAMME PRODUCT SUPPLY AGREEMENTMedical Need Programme Product Supply Agreement • January 16th, 2012
The Prescriber wishes to prescribe bendamustine hydrochlorise (Levact®) (“Product”) for administration to his/her particular named patient/s for the treatment or relapse or refactory multiple myeloma (“Patients”).
